TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -3 | 1 | -9 | -22 | 29 | 12 | 1 |
| P | %wins | 0 | 100 | 0 | 0 | 100 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/13/23 17:05 | 2/9/23 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Landis John B. | MA | D | M.d | 0 | 0.00 | 0 | 3 | 36 | 11 | D | |||||||||||||||
2/11/22 16:54 | 2/9/22 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Landis John B. | MA | D | M.d | 0 | 0.00 | 0 | 3 | 42 | 8 | D | |||||||||||||||
3/2/21 19:21 | 2/28/21 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Landis John B. | MA | D | M.d | 0 | 0.00 | 0 | 2 | 48 | 6 | D | |||||||||||||||
5/15/19 16:55 | 5/13/19 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Landis John B. | MA | D | P | 70 | 1.74 | 0 | 40 | New | 40 | D | |||||||||||||||
8/20/12 18:03 | 8/17/12 | BASI | Bioanalytical Systems Inc | IN | Health | Biolab | Commercial Physical & Biologi | Landis John B. | IN | D | P | 38 | 1.26 | 0 | 30 | New | 30 | D | 20 | -30 | -10 | -8 | 15 | 3 | 8 | 3 | -3 | 1 | -9 | -22 | 29 | 12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |